DelveInsight

Nov 03, 2017

AstraZeneca and Incyte Collaborate; Tocagen’s therapy; FDA warns companies;FDA Revokes

Oct 16, 2017

Wet AMD: A chronic eye condition with promising therapies

Oct 10, 2017

Novo petitions FDA;J&J invests; Xarelto’s trial; Roche’s Tecentriq

Oct 09, 2017

Natural Killer Cell Therapies– Advancing technology increasing competition among the companies

Oct 06, 2017

C-X-C Chemokine Receptor Inhibitors–The Emerging Therapeutic Agents

Sep 28, 2017

Alzeimer’s drug; Guardant Health receives approval; First Patient Dosed in Phase 1 Clinical Trial; Sunny Pharmtech and Vitruvias Therapeutics Receive FDA Approval

Sep 22, 2017

Isocitrate dehydrogenase (IDH) inhibitors– Emerging Anti-Cancer Therapeutics

Sep 20, 2017

Business Cocktail

Sep 18, 2017

Oral Mucositis – A Common Cancer Therapy Adverse Reaction

Sep 15, 2017

Business cocktail

Newsletter/Whitepaper